A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
O'Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, Philip NM, Cheung YK, Gupta V, João E, Pilotto JH, Diniz MP, Cardoso SW, Abrams D, Rajagopalan KN, Borden SE, Wolf A, Sidi LC, Vizzoni A, Veloso VG, Bitan ZC, Scotto DE, Meyer BJ, Jacobson SD, Kantor A, Mishra N, Chauhan LV, Stone EF, Dei Zotti F, La Carpia F, Hudson KE, Ferrara SA, Schwartz J, Stotler BA, Lin WW, Wontakal SN, Shaz B, Briese T, Hod EA, Spitalnik SL, Eisenberger A, Lipkin WI.
O'Donnell MR, et al. Among authors: spitalnik sl.
J Clin Invest. 2021 Jul 1;131(13):e150646. doi: 10.1172/JCI150646.
J Clin Invest. 2021.
PMID: 33974559
Free PMC article.
Clinical Trial.